GeneOne Life Science

011000 · KOSPI · Health Care · SMALL CAP

[Amended] Material event report (decision to sell own convertible bonds)

Capital raise([Amended] Material event report (decision to sell own convertible bonds))· FILED 2026-04-28· RCEPT 20260427000764

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-30) →

About this filing

The company is reselling convertible (or similar) bonds it had bought back, which brings their conversion rights back into the market.

Why companies file it: Resale of treasury bonds is disclosed because it can add future share supply.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-04-28, [Amended] Material event report (decision to sell own convertible bonds)
SourceDART rcept 20260427000764 → open original filing

Versions of this filing

  1. 2026-04-20Original
  2. 2026-04-28Amendment 1 (this page)
  3. 2026-05-29Amendment 2
  4. 2026-07-30Amendment 3

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-04-28 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).